Pepscan
Edelhertweg 15
Lelystad
8219 PH
Tel: 31-320 237205
Fax: 31-320-238120
Website: http://www.pepscan.nl/
Email: info@pepscan.nl
20 articles about Pepscan
-
CORRECTING and REPLACING Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan
7/4/2022
Biosynth Carbosynth (“Biosynth”), a supplier of critical products and services to the life sciences industry, announces today the acquisition of Pepscan, an expert provider of peptide-based products & services.
-
California-based Dren Bio and Pfizer have partnered on a deal valued at more than $1 billion to discover and develop therapeutic bispecific antibodies for select oncology targets.
-
Viewpoint Molecular Targeting(R) Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program
7/7/2021
Companies forge relationship to accelerate peptide drug discovery for next-generation radiopharmaceuticals Pepscan brings proprietary world-leading peptide drug discovery expertise and technologies
-
Pepscan Doubles GMP Production Capacity to Facilitate Clients' Growth
10/8/2019
Pepscan announced that its GMP production capacity has doubled.
-
Pepscan Produces Clinical Peptides for Innovative Personalized Cancer Vaccine Trial
6/25/2019
Pepscan is solely responsible for production of clinical neoantigen peptides, tailored to tumors of individual patients.
-
Potential Breakthrough Therapy For Cancer Based On Pepscan's CLIPS Technology
7/6/2017
-
Pepscan Achieves Milestones in Research Collaboration With Janssen R&D Ireland
2/8/2012
-
Pepscan Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference
12/7/2011
-
Phylogica Ltd. and Pepscan Enter Collaboration to Optimise Therapeutic Phylomer(R) Drug Candidates
5/10/2011
-
Zealand Pharma and Pepscan Awarded EU Grant of EUR 0.9 Million for the Joint Development of Novel Peptide Drugs
3/22/2011
-
Mercator Therapeutics and Pepscan Establish Research and Licensing Collaboration
1/3/2011
-
Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
4/28/2010
-
Pepscan Strengthens Management Team
1/27/2010
-
Dutch Biotech Company Pepscan Appoints New CEO
12/2/2009
-
Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology
4/6/2009
-
Pepscan Achieves First Milestone in Research Collaboration With Genmab A/S
3/10/2009
-
Pieris and Pepscan Systems to Identify GPCR-Specific Anticalins(R) Using CLIPS(TM) Protein Mimicry Technology
10/30/2007
-
Bill & Melinda Gates Foundation Selects Pepscan Systems's CLIPS(TM) Technology For HIV Booster Vaccine Development
10/31/2006
-
Pepscan Systems Secures Euro 7 Million In Its Second Financing Round And Launches Its Phase I/II GNRH Vaccine Trial For The Treatment Of Hormone Dependant Prostate Cancer
9/19/2006
-
Pepscan Systems Announces The Appointment Of Kenneth Freeman, As CFO
12/13/2005